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Abstract
The paper focuses on the practice of social prescribing as it is currently implemented
through the National Health Service (NHS) of the United Kingdom. Social Prescribing is an
emerging healthcare intervention aimed at referring patients to community-based activities. NHS
promotes social prescribing as a method of reducing healthcare utilization in chronically ill
patients. Current evidence on social prescribing is subject to significant variation and has not
supported NHS’s claims. The potential link between feeling of social isolation, loneliness and
chronic illness was further investigated through data from the National Social Life, Health &
Aging Project (NSHAP). Data was tested for correlations between respondents’ self-report of
heart problems (chi-squared) and systolic blood pressure (Pearson’s correlation), in relation to
survey measures on subjects’ level of social isolation and loneliness. To control for common
comorbidities of cardiovascular disease, respondents were excluded if they reported current
smoking status, diagnosis of diabetes, or waist measurements relating to obesity. Logistic and
linear regression was then performed to identify predictive models for self-reported heart
problems and systolic blood pressure respectively. The study provides limited evidence for to
support the impact of social prescribing. This limitation is driven by the high degree of variation
amongst reported outcomes. Future policy initiatives should focus on developing the body of
literature and establishing clear expectations for patient prognosis.
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Keywords:
Long Term Health Condition- Ongoing illnesses which cannot be cured, but can be effectively
managed through healthy patient habits and medical intervention.
Loneliness- The subjective feeling of disconnection from those around you.
Social Isolation- The persistent absence of social contact.
Social Prescribing- The process of referring a patient to community-based activities.
List of abbreviations
CVD- Cardiovascular Disease
EHR- Electronic Health Record
GP- General Practice/Practitioner
NHS- National Health Service
NORC- Non-partisan and Objective Research Organization
NSHAP- National Social Life, Health & Aging Practice
OHCA- Out of Hospital Cardiac Arrest
USCB- United States Census Bureau
USD-United States Dollar

3

Table of Contents
List of Abbreviations
I.Introduction......................................................................................................5
Social Prescribing Background………………………………………...6
Social Prescribing in Practice………………………………………….7
Healthcare utilization…………………………………………………..9
What is Successful Social Prescribing…………………………………9
Barriers………………………………………………………………..10
Social Isolation vs. Loneliness………………………………………..10
II.Methods..........................................................................................................12
Data Source……………………………………………………………12
Demographics…………………………………………………………13
Variable Selection……………………………………………………..13
Statistical Analysis…………………………………………………….15
III.Results...........................................................................................................15
Heart Problems and Social Isolation…………………………………..15
Heart Problems and Loneliness……………………………………......16
Systolic Blood Pressure and Social Isolation………………………….17
Systolic Blood Pressure and Loneliness……………………………….17
Limitations……………………………………………………………..17
IV.Discussion......................................................................................................19
Conclusions…………………………………………………………….20
References...........................................................................................................21

4

Introduction
Social prescribing is an emerging healthcare practice targeting individuals experiencing
social isolation and loneliness (NHS, n.d). Through social prescribing programs, healthcare
professionals can refer patients to a variety of community activities. In the United Kingdom, the
National Health Service (NHS) has begun developing infrastructure within general practices to
facilitate social prescribing. The NHS suggests that social prescribing can benefit individuals
experiencing an array of long-term health conditions (NHS, nd). However, the specific
conditions that can be addressed remain unclear. There is also confusion regarding the
directionality of potential interactions between social isolation, loneliness, and chronic health
outcomes. Do these negative social experiences negatively impact one’s health, or does poor
health promote negative social experiences? There is value in understanding these dynamics
when analyzing social prescribing’s reported ability to decrease healthcare utilization (Sheffield,
2014).
The NHS’s claims on the efficacy of social prescribing warrant further investigation.
Genuine questions remain regarding who can benefit from the service. This paper will attempt to
analyze this issue through two methods. The first is a comprehensive review of current literature
and practice of social prescribing. The second is a statistical analysis of the relationships
between social isolation, loneliness and outcomes associated with the long-term health condition,
cardiovascular disease (CVD). Through this analysis the paper aims to determine whether CVD
patients are at higher risk for experiencing social isolation and loneliness. Through assessing
these items, the paper will attempt to describe the current understanding of social prescribing as
an intervention for long term health conditions.
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Social Prescribing Background
Social prescribing is an emerging practice targeting lonely and socially isolated
individuals. Through social prescribing, healthcare providers refer clients to community-based
activities. (Ewbank, 2020) The aim of social prescribing is to address patient care holistically.
This means viewing a patient’s health in the context of their specific needs and abilities.
(Ewbank, 2020) Social prescribing patients attend community-based programs focusing on
topics such as: volunteering, performing arts, group learning, cooking, and physical activity. The
nature of the activities one attends is based heavily on the patients stated goals, abilities, and
motivation.
While social prescribing programs have existed in the United Kingdom since the 1980s,
the last decade has seen the NHS formally integrate these programs into General Practice (GP)
systems (Ewbank, 2020). NHS’s Five Year Forward Review, (NHS, 2014) laid out a roadmap for
developing new models of care. The report emphasized the need for new, patient-centered
programs. The NHS hoped to utilize this novel treatment intervention to reduce overall burden
on the healthcare system. (NHS, 2014) The NHS review highlighted a social prescribing pilot
program in Rotherham. The program was noted for its ability to reduce out-patient appointments
and hospital admissions.
In 2019, the NHS under the Universal Personalized Care program, began incorporating
social prescribing in its general practice system (NHS, nd.). The link worker is a non-clinical
role, focused on connecting clients with appropriate social prescribing programs. Link workers
typically receive clients through referral from a GP and meet with individuals over a 3-month
period consisting of approximately 6 individual sessions. (NHS, nd.) During these meetings the
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link worker helps the individual identify appropriate community programs based on their stated
treatment goals. The NHS aims to recruit 1,000 link workers by 2021, with the goal of serving up
to 900,000 patients by 2024. (NHS. Nd.)
Social prescribing programs can receive funding through a variety of sources. This can
include funding through Clinical Commissioning groups, local governments, and grants (Polley
et al., n.d.). There are no clear guidelines for how this funding should be deployed. Individual
social prescribing schemes can make decisions on allocating funding based on the needs of their
community. The current NHS contract secures five years of funding for primary care networks
serving at least 30,000 patients to employ a full-time link worker (Ewbank, 2020). It is difficult
to obtain clear estimates for the offsetting of cost through reduced healthcare utilization.
Additionally, £5 million ($6.95 million USD) of funding has been allocated to establish a
National Academy of Social Prescribing. The academy is tasked with developing standardized
models of social prescribing, best practice standards and accreditation guidelines (Department of
Health and Social Care, 2019).
Social prescribing in practice
The Rotherham pilot program was commissioned by NHS Rotherham in 2012. The pilot
received £1.1 million ($1.53 million USD) in grant funding through the NHS covering a period
of two years. Approximately 56% of the program were allocated for developing a roster of
Voluntary and Community Sector (VCS) activities. The remaining 44% was used for program
cost related to developing and running the pilot. The pilot offered a total of 31 services
provided by 24 unique organizations. A total of 30 GP sites participated in the pilot. The pilot
cohort consisted of 1,607 patients, 87% of the pilot cohort were age 60 or older. Females
comprised 61% of the pilot cohort (39% Male), while whites accounted for 91% of the cohort.
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The most popular programs focused on information and advice (n=248), community activity
(n=246), physical activity (n=172), and befriending (n=167). 1,118 patients were referred to a
funded VCS and the remainder were referred to non-funded services.
After six months patients saw a 14% overall reduction in inpatient admissions. For
patients who participated in the program for one year, overall inpatient admissions were reduced
by 21%. 27% of patients referred to a funded VCS for six months saw a reduction in inpatient
services. This reduction in inpatient admissions was seen in 48% of patients referred to a funded
VCS for one year. For the six-month group 30% of patients referred to a funded VCS saw a
reduction in outpatient appointments. In the one-year group, 55% of patients referred to a
funded VCS experienced a reduction in outpatient appointments.
One shortcoming of the Rotherham pilot is the lack of reporting on patient diagnoses, and
corresponding services utilized. The results were based on the entire cohort which received
differing services for a multitude of reasons. One could argue that this heterogeneity
supports the notion that social prescribing is responsible for the observed outcomes. However,
there is also evidence that this heterogeneity could skew observed results as well. Another social
prescribing program in South Devon (N=151) found that mean healthcare cost rose by 66.7%,
despite overall measures of quality of life saw improvement. This result was attributed to 12
medically frail individuals who saw marked declines in health over the study period. This
outcome highlight the fact that in heterogeneous samples, there may be underlying trends which
influence the final results. The identification of such trends can help researchers understand
when social prescribing is beneficial, and when it isn’t. Following up on the South Devon data,
one may ask whether the social prescribing program influenced the subject worsening health.
Perhaps the social prescribing activity the individual attended was beyond their physical abilities.
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Healthcare Utilization
While the Rotherham pilot program reported significant decreases in healthcare
utilization, the broader body of evidence is less clear. Previous research has reported reductions
ranging from 2% to 70% in care utilization (Polley et al., 2017). As described above, these
results could be attributed to the wide variance in both patients referred and services offered.
Furthermore, studies following individual cohorts from a single GP or social prescribing
program are likely to have a low number of subjects. Even within these small cohorts, subjects
are likely to referred to a variety of activities for varying conditions (Mason et al., 2019). This
limits our ability to draw meaningful conclusions from their data (Loftus et al., 2017).
However, in one study was found (Polley et al., 2019) in which subjects were organized with a
case-matched control groups based on diagnosis of cardiovascular disease, age and gender
(N=105). Results of the study showed that GP visits were reduced by 40% for the social
prescribing group.
What is Successful Social Prescribing?
The variability in program design and reported outcomes, leaves doubt regarding what
“successful” social prescribing is. The NHS has designed its social prescribing initiatives around
the guiding principle that patients should be active participants in the planning and delivery of
their care. Central to this principle is an acknowledgement of the patient’s values and goals.
Currently, the best practice for “successful” outcomes may be to focus on the patient-centered
nature of the treatment. Evidence suggests that patients are more likely to participate in a social
prescribing program when they enter with positive attitudes and expectations (Husk et al., 2019).
Attitudes promoting participation include dissatisfaction with one’s current treatment
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interventions and the belief that social prescribing could positively affect their condition. It
could be that patients that enter treatment with positive expectations may be more aware of
positive changes they experience.
Barriers
Given the novelty of social prescribing schemes, some GPs may lack the
understanding or resources to begin referring patients. For example, GPs may be unfamiliar with
their communities’ resources. The role of the link worker is intended fill this gap in information,
but some GPs may not feel confident with the link worker’s level of training of expertise.
Additionally, the lack of evidence-based standards may make conversations about treatment
course and benefits difficult for GPs (Fixsen, et al., 2020). As a result, GPs may avoid
discussing social prescribing in favor of more familiar medical interventions. The local contexts
of social prescribing programs have hindered the development of standardized models of
evaluation. (Husk et al., 2019) Social prescribing referrals are inherently limited to what is
available in the community. As a result, patients can receive significantly different services at
varied intervals.
Social Isolation vs. Loneliness
While social isolation and loneliness are at times used interchangeably, the two have
meaningful differences. Social Isolation refers to the objective absence of human contact
(Veazie et al., 2019). Alternatively, loneliness is the subjective feeling of alienation from those
around them. Effectively, loneliness is the perception that one is socially isolated. (Donovan &
Blazer, 2020) While both experiences can, and often do, occur simultaneously, they are not
synonymous. One can interact with multiple people each day, but feel they have no one to “open
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up to.” Conversely, an individual may spend long periods of time at home alone but are still
satisfied with the time they do get to spend with friends and family.
From the perspective of healthcare, it is a worthwhile to distinguish between the above
experiences. Both experiences have the potential to negatively influence one’s health in unique
ways. The lonely individual may be at higher risk for increased stress and worse mental health.
The socially isolated individual may fail to get adequate physical activity. They could also
struggle to meet their basic needs, when doing so requires travel outside the home. Each
individual has unique needs that may be amenable to treatment.
Social isolation, Loneliness, and Health
Valtorta et al. (2018) examined Cardiovascular Disease (CVD) in the context of both
social isolation and loneliness. The 6-year longitudinal study found that while social isolation
was not associated with increased risk of CVD, self-reported loneliness was. This was true of
any individual who reported loneliness over the 6-year period. The frequency of reported
loneliness was not found to have a cumulative effect on CVD risk.
There is evidence linking social isolation and loneliness to mortality (Holt-Lunstad et al.,
2015). The nature of their interaction is unclear. There is some evidence that individuals who
are both socially isolated and lonely have a significantly higher risk of mortality, compared to
individuals who endorse only one experience (Beller et al., 2018). Conversely, other literature
supports that social isolation has the greatest risk of all-cause mortality (Steptoe et al., 2013). In
the context of CVD, social isolation was not found to correlate with risk of developing CVD, but
was found to increase the risk of mortality following a cardiac event (Smith et al., 2021) .It is
important to note that this trend was only present in individuals who were not admitted to the
hospital following the event.
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These results suggest that social isolation may not directly impact the development or
progression of CVD. Instead, socially isolation may increase risk for complications from CVD
due to a lack of access to immediate help. If an individual spends large amounts of time alone,
they are less likely to have someone near to administer aid during a cardiac event. Out of
Hospital Cardiac Arrest (OHCA) accounts for 70% of all instances of cardiac arrests in the
United States. (Heart.org, n.d.) Immediate intervention through bystander Cardiopulmonary
Resuscitation is a significant predictor of survival. (Vierek, 2017) Socially isolated individuals
are less likely have someone available to administer these services in the event of an acute
cardiac event.
Methods
Data Source
The data used in this study originated from the National Social Life, Health & Aging
Project (NSHAP) (NSHAP, nd). NSHAP is conducted through the non-partisan and objective
research organization (NORC) at the University of Chicago. NSHAP is a multidimensional
longitudinal study focused on older adults in the United States. Data from three cohort waves
have been collected thus far, Cohort One Wave One (C1W1) 2005-2006, Cohort One Wave Two
(C1W2) 2010-2011, and Cohort One Wave Three (C1W3) 2015-2016. This study used data
obtained from C1W3 consisting of 4,777 total subjects. Data was collected through in-person
interviews, recording of biological measures, and supplement leave behind questionaries. The R
data file, and corresponding code book were downloaded from the NSHAP website
https://www.icpsr.umich.edu/web/NACDA/studies/36873/datadocumentation#.
Demographics
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The mean age for all participants was 67.63. For males the mean age was 67.57. For
females the mean age was 67.69. The study consisted of 2,374 female participants and 2,003
male participants. 3,194 participants identified as White, 719 participants identified as Black, and
452 identified as Asian, Pacific Islander, American Indian or Alaskan native. 2,755 participants
reported being married (Male=1,461, Female=1,294). 149 unmarried participants reported living
with a partner (Male=66, Female=73). For the purpose of the statistical analysis, individuals
who reported current smoking status, diagnosis of diabetes, or waist diameter above a certain
threshold (males=40in, females=34.5, males & females combined=37.25). After adjusting for
these variables the analysis consisted of 256 females, 235 males, and 547 for the combined male
and female group.
Variable Selection
Dependent variables were categorized as relating either to social isolation or loneliness.
Items that referenced objective measures regarding frequency of interaction with others and daily
levels of activity, were categorized as pertaining to Social Isolation. These measures included
items such as, marital or relationship status, and frequency of attending organized events (Table
1). In total 7 items were categorized as relating to social isolation. Social isolation items were
presented as ratings of the frequency of an activity, ranging from 0 (never) to 6 (several times a
week). Exceptions to this format were marital status which ranged from 1 (married) to 6 (never
married). Items that referenced the subject’s subjective feelings on their relationships were
categorized as pertaining to loneliness (Table 2). All loneliness variables were also presented on
a Likert scale ranging from 0 (never) to 3 (often).
Two measures relating to participants’ cardiovascular health were used as dependent
variables. The first was the subject’s self-report of having been told by a doctor that they have a
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heart problem. This measure did not ask the subject to disclose the exact nature of the heart
problem. The definition of “doctor” excluded chiropractors, dentists, nurses, and nurse
practitioners. The second variable was the participants systolic blood pressure. Blood pressure
was in two separate instances. For this analysis the systolic blood pressure from the second
reading was used. To account for comorbidities associated with CVD, three control variables
were identified, weight, diabetes diagnosis, and smoking status.

Variable
Marital Status
Romantic
Partner
Volunteering
Attending
groups/events
Socializing
Attending
services

Social Isolation Variables
Definition
Current Marital Status
Current Relationship Status (if unmarried)
Frequency of volunteering in the past year
Frequency of attending organized meetings in the past year
Frequency of socializing with friends and/or family in the last year
Frequency of attending religious services in the past year

Table 1 The variables categorized as addressing social isolation, and corresponding definitions

Variable
Left Out*
Isolated *+
Companion*
Family
openness
Friends
openness
Family
Understanding
Friends
Understanding
Happiness

Loneliness Variables
Definition
How often do you feel left out?
How often do you feel isolated?
How often do you feel you lack companionship?
How often can you open up to family?
How often can you open up to friends?
How often does family understand how you feel?
How often do friends understand how you feel?
Self-rated happiness
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Table 2 The variables categorized as addressing loneliness. (*) Variables comprising the UCLA
loneliness scale. (+) Refers to the subjects’ subjective feelings of isolation, thus was coded as relating
to loneliness.

Statistical Analysis
Chi-squared tests were used to analyze the relationship between subjects’ self-reported
heart problems and the designated social isolation and loneliness variables. Pearson’s correlation
was used to compare the variable of systolic blood pressure to the social isolation and loneliness
variables. Analysis was performed for the entire sample, as well as male and female subgroups.
To control for cardiovascular disease comorbidities, smokers, diabetics, and respondents above a
certain waist size were removed. Logistic and linear regression were used to identify potential
predictive models for variables that reached statistical significance in the previous analysis.
Statistically significant variables underwent logistic regression or linear regression for selfreported heart problems and systolic blood pressure respectively. All statistical analysis was
performed using R Studio version 1.2.5033 run on MacOS version 10.15.7.
Results
Heart problems and social isolation
The chi-squared analysis for the male and female group revealed significant relationships
between physical activity (X2(5) = 16.90, p= 4.69e-3), volunteering (X2(6) = 18.33, p= 0.01), and
self-reported heart problems. A logistic regression analysis was performed to assess
the relationship between physical activity and self-reported heart problems for both females, and
the combined male and female group (p= 1.38e-3) with R2=0.08. Males and females predicted
likelihood of a reported heart problem is equal to -1.18-1.12(<once per month)-16.39(1-3 times
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per month)-1.11(1-2 times per week)-1.07(3-4 times per week)-1.36(> 5 times per week). A
significant linear model for volunteering and self-reported heart problems was not identified.

Chi-squared results Heart Problems and Social Isolation
Variable
Male and female
Physical Activity
Volunteering

X2

df
5
6

16.9
18.33

p-value
4.69E-03
0.01

Table 3 Measures of social isolation which reached significance after controlling for
confounding variables.

Heart problems and loneliness
The chi-squared analysis revealed several significant interactions between self-reported
heart problems and measures of loneliness, happiness for males (X2(4) = 11.05, p= 0.03),
feelings of isolation for females (X2(3) = 11.80, p= 0.01), and feelings of isolated for both males
and females (X2(3) = 17.95, p= 4.52e-04). A logistic regression analysis was performed to assess
the relationship between self-reported feelings of isolation and self-reported heart problem for
both females, and the combined male and female group. A significant logistic equation was
identified for males and females, (p=0.01) with an R2=0.05. Males and females predicted
likelihood of a reported heart problem is equal to -2.56-.022(Hardly ever feels
isolated)+0.54(Sometimes feels isolated)+ 2.09(Often feels isolated). A logistic regression
analysis for self-reported heart problems and males’ happiness failed to reach significance.
Likewise, the logistic regression for females self-reported feelings of isolation and self-reported
heart problems failed to reach significance.
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Chi-squared results Heart Problems and Loneliness
Variable
df
X2
p-value
Male
Happiness 4
11.05
0.03
Female
Feeling Isolated

3

11.8

0.01

Feeling Isolated

3

17.95

4.52E-04

Combined

Table 4 Loneliness variables which reached statistical
Significance after controlling for confounding variables.

Systolic blood pressure and social isolation
Results of the Pearson’s correlation analysis revealed two significant relationships for
systolic blood pressure. For males, marital status was found to be significant (r= 0.16, p=0.02).
For both males and females, attending religious services was found to be significant (r=-0.009,
p=0.05). Neither variable was able to produce a statistically significant linear model.
Pearson's correlation results for Systolic Blood
Pressure and Social Isolation
Variable
r
p-value
Male
Marital Status
0.16
0.02
Combined
Attending Services

-0.009

0.049

Table 5 Social Isolation variables that reached statistical
significance.
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Systolic blood pressure and loneliness
Results of the Pearson’s correlation analysis revealed two significant relationships for
systolic blood pressure. For males, happiness was found to be significant (r= -0.18, p=0.01).
For females, feeling isolated services was found to be significant (r=-0.17, p=0.01). No
significant relationships were found within the male and female groups. A simple linear
regression was calculated to predict Systolic blood pressure based on males’ happiness. This
model failed to reach statistical significance. A second linear regression was calculated to
predict systolic blood pressure based on females’ feelings of isolation. For this relationship a
significant regression equation was found (F(3,204)=3.265, p=0.02), with an R2 of 0.03.
Females’ predicted weight is equal to 126.32-6.96(Hardly ever isolated)-9.60(Sometimes
isolated)+0.43 (Often isolated).
Pearson's correlation results for Systolic Blood
Pressure and Loneliness
Variable
r
p-value
Male
Happiness -0.18
0.01
Female
Isolated -0.17
0.01
Table 6 Loneliness variables that reached statistical
Significance.

Limitations
This study had a number of limitations. The self-reported measure of heart problems may
have been too broad. The only criteria offered to respondents was that they had been given this
information from a medical doctor. Respondents could have under or over reported heart
problems based on how they interpreted the question, and information they received from their
GP. A more conclusive comparison could use specific diagnoses from medical records or
claims. The Likert scale ratings for loneliness are also subject to interpretation. Phrases such as
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‘often” and “some of the time” could be interpreted drastically differently from subject to
subject. A more effective measure may reframe the items in terms of satisfaction with these
interactions.

Discussion
The results of the data analysis offered inconsistent support for a relationship between
cardiovascular disease and measures of social isolation and loneliness. Males showed limited
correlation between social isolation and loneliness measures and both heart health variables.
Furthermore, variables that were found to be significant typically focused on measures such
as marital status and general happiness. Variables which included more specific measures of
time spent on social activities and feelings on one’s relationships were predominately nonsignificant. The only exception to this trend was the relationship between volunteering and selfreported heart problems, prior to accounting for controls, and one’s families’ understanding their
feelings after accounting for controls. Prior to accounting for controls women’s measures of
heart health correlated with a wider range of social isolation and loneliness measures.
These data, along with the existing body of literature, suggests the greatest barrier to
implementing effective social prescribing is the lack of consistent, validated evidence. The
current evidence provides the strongest support for utilizing social prescribing only as a
supplement to traditional care when it aligns with the patient’s goals. GPs should be cautious not
to overstate the potential health benefits to the patient.
NHS should take steps to improve the quality of evidence surrounding social prescribing.
Funding and resources may better spent on policy initiatives such as the National Academy of
Social Prescribing, than in the development of individual programs. A greater body of evidence
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would help government and healthcare officials make more informed choices regarding future
funding initiatives. Under the NHS’s current trajectory, there is a risk of developing
infrastructure and resources that ultimately do not fulfil their intended purpose. The NHS may
find that considerable funding has been spent on resources that fail to produce benefits in patient
outcomes or cost control.
This goal could be further aided by establishing a national database of social prescribing
Patients through electronic health records (EHR). This database could help fill in gaps of
information which limit current research. An effective database should account for information
including, demographics, geographic location, diagnosis, program referrals, and program
attendance. Such a database could improve research design by allowing for larger cohorts
matched across factors such as diagnosis and program.
Conclusion
Social prescribing is a novel form of healthcare that attempts to address patients’ health
issues while promoting socialization and general well-being. The NHS has made considerable
efforts to build-out social prescribing infrastructure. While GPs are being encouraged to promote
the practice with their patients, the poor evidence base remains a barrier to effective utilization.
Questions remain regarding whether chronic illnesses can be positively impacted by social
prescribing. The efficacy of individual social prescribing activities also requires further analysis.
The NHS has ambitious goals for expanding its social prescribing programs. However, these
efforts appear premature given the lack of evidence supporting them. To develop an effective
social prescribing program, current efforts should be focused on refining the means of data
collection and developing a more robust body of literature.

20

Reference

Beller, J. , Wagner, A. & Freedland, K. E. (2018). Loneliness, Social Isolation, Their Synergistic
Interaction, and Mortality. Health Psychology, 37(9), 808–813. doi: 10.1037/hea0000605.
Department of Health and Social Care. (2019, October 23). Social prescribing: New national
academy set up. Retrieved 2021, from https://www.gov.uk/government/news/socialprescribing-new-national-academy-set-up
Elston, J., Gradinger, F., Asthana, S., Lilley-Woolnough, C., Wroe, S., Harman, H., & Byng, R.
(2019). Does a social prescribing ‘holistic’ link-worker for older people with complex,
multimorbidity improve well-being and frailty and reduce health and social care use and
costs? A 12-month before-and-after evaluation. Primary Health Care Research &
Development, 20. doi:10.1017/s1463423619000598
Ewbank, D. B. L. (2020). What is social prescribing? The King's Fund.
https://www.kingsfund.org.uk/publications/social-prescribing.
Fixsen, A., Seers, H., Polley, M., & Robins, J. (2020). Applying critical systems thinking to
social prescribing: A relational model of stakeholder “buy-in”. BMC Health Services
Research, 20(1). doi:10.1186/s12913-020-05443-8
Heart disease facts. (2020). Retrieved April 15, 2021, from
https://www.cdc.gov/heartdisease/facts.htm
Holt-Lunstad, J. (2018, January 2). Potential Public Health Relevance of Social Isolation and
Loneliness: Prevalence, Epidemiology, and Risk Factors. OUP Academic.
https://academic.oup.com/ppar/article/27/4/127/4782506?login=true.
NHS. NHS Choices. https://www.england.nhs.uk/personalisedcare/social-prescribing/.
NHS. NHS Choices. https://www.england.nhs.uk/personalisedcare/social-prescribing/faqs/
Polley, M., Fleming, J., & Anfilogoff, T. (n.d.). Making sense of Social Prescribing. Retrieved
fromhttps://westminsterresearch.westminster.ac.uk/download/f3cf4b9495
11304f762bdec137844251031072697ae511a462eac9150d6ba8e0/1340196/Making-senseof-social-prescribing%202017.pdf

21

Polley, M.J. and Pilkington, K. 2017. A review of the evidence assessing impact of social
prescribing on healthcare demand and cost implications. University of Westminster.
https://westminsterresearch.westminster.ac.uk/item/q1455/a-review-of-the-evidenceassessing-impact-of-social-prescribing-on-healthcare-demand-and-cost-implications
Polley, M., Seers, H., & Fixsen, A. (2019). Evaluation Report of the Social Prescribing
Demonstrator Site in Shropshire. University of Westminster. https://42b7de07-529d-4774b3e1-225090d531bd.filesusr.com/ugd/14f499_131547f575344dcdbf4c8281f80ea18c.pdf
Vigorito, C., & Giallauria, F. (2018). Loneliness, social isolation and risk of cardiovascular disease
in the English Longitudinal Study of Ageing. European Journal of Preventive Cardiology,
25(13), 1384–1386. https://doi.org/10.1177/2047487318793456

22

